FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913665794> ?p ?o ?g. }

• W2913665794 endingPage "1114" @default.
• W2913665794 startingPage "1109" @default.
• W2913665794 abstract "The adoptive cell transfer of select tumor-infiltrating lymphocytes (TILs) for personalized immunotherapy can mediate long-term objective tumor regressions in patients with metastatic melanoma, bile duct, cervix, colon, and breast cancers (1–5). These clinical responses are likely mediated by recognition of mutated gene products termed neoantigens because they are absent in normal tissues. Intratumoral T cell responses to mutated neoantigens identified thus far have been unique to the patient, i.e., they are private mutations not identified in other patients’ tumors, except for a neoepitope arising from the KRASG12D driver mutation (1, 3). However, it is largely unknown whether naturally occurring T cells within tumors recognize other shared mutated neoantigens expressed by cancers of unrelated patients.Across all cancer types, TP53 is the most commonly mutated gene, but mutations occur throughout the gene with preference in the DNA binding domain (6, 7). Therapeutic approaches evaluating small-molecule inhibitors and T cells targeting both WT and mutant p53 tumors in mouse models have been described (8–11). Preliminary studies provided some evidence that mutated TP53 could be recognized by peripheral blood T cells after in vitro stimulation and in vivo vaccination (12–14). However, evidence of immune responses to mutated TP53 within human tumors is limited even though most tumors will express a TP53 mutation. We previously reported patient-specific neoantigen screening in 7 patients with metastatic ovarian cancer, 2 of whom had mutated TP53 neoantigens restricted by HLA-DRB3*02:02 (15, 16). Here, we developed a novel strategy to systematically and comprehensively analyze intratumoral T cell responses to defined TP53 hot spot mutations independent of other tumor mutations in 133 new patients with multiple tumor types. The goal was to translate these cells or their TCR genes into broadly applicable adoptive cellular therapies for common epithelial malignancies." @default.
• W2913665794 created "2019-02-21" @default.
• W2913665794 creator A5000186155 @default.
• W2913665794 creator A5003770095 @default.
• W2913665794 creator A5018045451 @default.
• W2913665794 creator A5031216154 @default.
• W2913665794 creator A5032277455 @default.
• W2913665794 creator A5039151855 @default.
• W2913665794 creator A5051448151 @default.
• W2913665794 creator A5052884530 @default.
• W2913665794 creator A5054506899 @default.
• W2913665794 creator A5058077037 @default.
• W2913665794 creator A5061987607 @default.
• W2913665794 creator A5070441911 @default.
• W2913665794 creator A5072133376 @default.
• W2913665794 creator A5080709444 @default.
• W2913665794 creator A5085672385 @default.
• W2913665794 creator A5088617435 @default.
• W2913665794 date "2019-02-04" @default.
• W2913665794 modified "2023-10-14" @default.
• W2913665794 title "Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers" @default.
• W2913665794 cites W1556274289 @default.
• W2913665794 cites W2013257892 @default.
• W2913665794 cites W2021472146 @default.
• W2913665794 cites W2033048285 @default.
• W2913665794 cites W2038181190 @default.
• W2913665794 cites W2047766643 @default.
• W2913665794 cites W2069452349 @default.
• W2913665794 cites W2095813207 @default.
• W2913665794 cites W2159895229 @default.
• W2913665794 cites W2201214180 @default.
• W2913665794 cites W2290520196 @default.
• W2913665794 cites W2472697448 @default.
• W2913665794 cites W2559953355 @default.
• W2913665794 cites W2607497548 @default.
• W2913665794 cites W2752942423 @default.
• W2913665794 cites W2765694924 @default.
• W2913665794 cites W2796408191 @default.
• W2913665794 cites W2805363059 @default.
• W2913665794 cites W2806895459 @default.
• W2913665794 cites W2895264449 @default.
• W2913665794 doi "https://doi.org/10.1172/jci123791" @default.
• W2913665794 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6391139" @default.
• W2913665794 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30714987" @default.
• W2913665794 hasPublicationYear "2019" @default.
• W2913665794 type Work @default.
• W2913665794 sameAs 2913665794 @default.
• W2913665794 citedByCount "176" @default.
• W2913665794 countsByYear W29136657942019 @default.
• W2913665794 countsByYear W29136657942020 @default.
• W2913665794 countsByYear W29136657942021 @default.
• W2913665794 countsByYear W29136657942022 @default.
• W2913665794 countsByYear W29136657942023 @default.
• W2913665794 crossrefType "journal-article" @default.
• W2913665794 hasAuthorship W2913665794A5000186155 @default.
• W2913665794 hasAuthorship W2913665794A5003770095 @default.
• W2913665794 hasAuthorship W2913665794A5018045451 @default.
• W2913665794 hasAuthorship W2913665794A5031216154 @default.
• W2913665794 hasAuthorship W2913665794A5032277455 @default.
• W2913665794 hasAuthorship W2913665794A5039151855 @default.
• W2913665794 hasAuthorship W2913665794A5051448151 @default.
• W2913665794 hasAuthorship W2913665794A5052884530 @default.
• W2913665794 hasAuthorship W2913665794A5054506899 @default.
• W2913665794 hasAuthorship W2913665794A5058077037 @default.
• W2913665794 hasAuthorship W2913665794A5061987607 @default.
• W2913665794 hasAuthorship W2913665794A5070441911 @default.
• W2913665794 hasAuthorship W2913665794A5072133376 @default.
• W2913665794 hasAuthorship W2913665794A5080709444 @default.
• W2913665794 hasAuthorship W2913665794A5085672385 @default.
• W2913665794 hasAuthorship W2913665794A5088617435 @default.
• W2913665794 hasBestOaLocation W29136657941 @default.
• W2913665794 hasConcept C104317684 @default.
• W2913665794 hasConcept C143065580 @default.
• W2913665794 hasConcept C159654299 @default.
• W2913665794 hasConcept C203014093 @default.
• W2913665794 hasConcept C2780868878 @default.
• W2913665794 hasConcept C502942594 @default.
• W2913665794 hasConcept C54355233 @default.
• W2913665794 hasConcept C70721500 @default.
• W2913665794 hasConcept C71924100 @default.
• W2913665794 hasConcept C86803240 @default.
• W2913665794 hasConceptScore W2913665794C104317684 @default.
• W2913665794 hasConceptScore W2913665794C143065580 @default.
• W2913665794 hasConceptScore W2913665794C159654299 @default.
• W2913665794 hasConceptScore W2913665794C203014093 @default.
• W2913665794 hasConceptScore W2913665794C2780868878 @default.
• W2913665794 hasConceptScore W2913665794C502942594 @default.
• W2913665794 hasConceptScore W2913665794C54355233 @default.
• W2913665794 hasConceptScore W2913665794C70721500 @default.
• W2913665794 hasConceptScore W2913665794C71924100 @default.
• W2913665794 hasConceptScore W2913665794C86803240 @default.
• W2913665794 hasFunder F4320337351 @default.
• W2913665794 hasIssue "3" @default.
• W2913665794 hasLocation W29136657941 @default.
• W2913665794 hasLocation W29136657942 @default.
• W2913665794 hasLocation W29136657943 @default.
• W2913665794 hasLocation W29136657944 @default.
• W2913665794 hasOpenAccess W2913665794 @default.

• next